Similarly, no disparities were evident in the median tumor marker levels (CEA 3.8 ng/mL vs. 4.1 ng/mL, CA19-9 13.5 U/mL vs. 19.4 U/mL) [14]. This evidence concerns the gene CEACAM5 and neoplasm.